Article
Epigenetic inactivation of the MIR34B/C in multiple myeloma
6 Oct 2011
Abstract excerpt
We postulated that MIR34B/C, a direct transcriptional target of TP53, might be inactivated by promoter hypermethylation in multiple myeloma (MM). MIR34B/C promoter methylation was studied in 8 normal marrow controls, 8 MM cell lines, 95 diagnostic, and 23 relapsed/progressed MM samples by methylation-specific PCR. MIR34B/C was methylated in 6 (75.0%) MM cell lines but not normal controls. 5-Aza-2'-deoxycytidine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
